Phil
Phil is a clinical trial budget specialist with 5 years building and reviewing investigator site budgets for sponsors and CROs. He has worked on a number of studies ranging from, from Phase I oncology to Phase IV observational studies, and now writes the practical guidance he wished he’d had as a junior analyst.
A Budget Builder’s Perspective on Observational Studies
Read MoreA Budget Builder’s Perspective on Observational Studies
What Is a Central Lab in Clinical Trials? Why Sponsors Use One
Read MoreWhat Is a Central Lab in Clinical Trials? Why Sponsors Use One
Central Lab vs. Local Lab: How It Changes Your Clinical Trial Budget
Read MoreCentral Lab vs. Local Lab: How It Changes Your Clinical Trial Budget
Protocol Amendments: Budget Impact & Delta Analysis
Read MoreProtocol Amendments: Budget Impact & Delta Analysis
Navigating the UK iCT: A Guide to NHS Clinical Trial Budgeting (with Key Differences vs France)
Read MoreNavigating the UK iCT: A Guide to NHS Clinical Trial Budgeting (with Key Differences vs France)
How French Clinical Trial Budgets Work: What’s Non-Negotiable and Where You Add Value
Read MoreHow French Clinical Trial Budgets Work: What’s Non-Negotiable and Where You Add Value
Budget Analyst Career Path: Where Do Budget Analysts Go Next? 12 Roles You Can Transition Into
Read MoreBudget Analyst Career Path: Where Do Budget Analysts Go Next? 12 Roles You Can Transition Into
Budget Analyst Career Path: How to Choose Your Next Career Move
Read MoreBudget Analyst Career Path: How to Choose Your Next Career Move
